abstract |
(57) [Problem] To provide a pharmaceutical composition useful in treating human prostate cancer. SOLUTION: A 5-α-reductase inhibitory compound such as 17β- (Nt-butylcarboxamido) -5-α-androst-1-en-4-aza-3-one and a pharmaceutically acceptable carrier are provided. A pharmaceutical composition for treating human prostate cancer, comprising: |